• Allosteric PDK4 Inhibitors: Advancing Metabolic Disease Ther

  2026-07-16

  This study identifies a new series of allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), with the lead compound 8c demonstrating potent in vitro and in vivo efficacy for metabolic disease models. The findings offer a validated scaffold for further drug development and highlight the therapeutic potential of PDK4 modulation in metabolic, allergic, and cancer contexts.

• Sabutoclax as a Pan-Bcl-2 Inhibitor: Precision Tools for Dis

  2026-07-16

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables nuanced analysis of apoptosis in cancer cells. This article reveals advanced strategies for distinguishing cell death from proliferation arrest, with practical insights for high-fidelity preclinical modeling.

• Biotin-HPDP in Thiol-Specific Protein Labeling: Protocols &

  2026-07-15

  Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) delivers reversible, high-sensitivity thiol-specific protein biotinylation for redox biology, S-nitrosylated protein detection, and advanced affinity workflows. This guide translates recent breakthroughs in cysteine palmitoylation and pyroptosis into actionable experimental strategies, troubleshooting, and protocol optimization.

• Haloprogin’s Broad-Spectrum Antifungal and Antibacterial Eff

  2026-07-15

  The reference study systematically establishes Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antimicrobial with robust in vitro and in vivo activity against dermatophytes, Candida species, and select Gram-positive bacteria. Its comparative evaluation with tolnaftate highlights Haloprogin’s unique spectrum and informs protocol design for dermatophytosis and Candida albicans infection research.

• CH 223191: Potent AhR Antagonist for Dioxin Toxicity Studies

  2026-07-14

  CH 223191 is a highly selective aryl hydrocarbon receptor antagonist validated for dissecting dioxin toxicity and AhR signaling with nanomolar potency. Its efficacy in modulating CYP1A1 expression and reducing TCDD-induced hepatic toxicity makes it a benchmark tool for environmental toxicology and regeneration research.

• KNUCKLES Controls Floral Meristem Termination via Hormone Re

  2026-07-14

  This study reveals that the C2H2-type zinc finger protein KNUCKLES (KNU) orchestrates the timely termination of the floral meristem (FM) in Arabidopsis by directly repressing key genes in auxin and cytokinin pathways. These findings clarify the molecular integration of hormonal signals and chromatin regulation during floral development, with implications for developmental timing and plant morphogenesis.

• ARCA Cy5 EGFP mRNA (5-moUTP): Redefining Quantitative mRNA T

  2026-07-13

  Explore how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables precise, quantitative analysis of mRNA delivery, trafficking, and translation in mammalian cells. This article reveals advanced assay strategies, protocol parameters, and stability insights not addressed in standard guides.

• Faropenem Sodium (SKU C8712): Reliable Antimicrobial for Lab

  2026-07-13

  Faropenem sodium (SKU C8712) is a penem antibiotic offering broad-spectrum activity and robust β-lactamase stability, making it a reliable choice for bacterial inhibition studies. This article addresses real-world laboratory challenges, illustrating how Faropenem sodium from APExBIO enhances reproducibility, sensitivity, and workflow safety in cell viability and antibiotic resistance assays.

• Dual-Action Inhibitors Modulate p38α MAPK Dephosphorylation

  2026-07-12

  The reference study uncovers how certain kinase inhibitors not only block p38α MAPK activity but also accelerate its dephosphorylation by stabilizing conformations accessible to phosphatases. This dual-action mechanism offers new strategies for improving the potency and specificity of p38α MAPK inhibitors in inflammation and autoimmune disease research.

• Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Epigenetic I

  2026-07-10

  Discover how the Phosphatase Inhibitor Cocktail (2 Tubes, 100X) preserves protein phosphorylation and enables accurate dissection of phospho-signaling and epigenetic regulation. This article uniquely connects biochemical assay workflows with recent advances in understanding MAPK pathway control and histone modification.

• Temafloxacin in Advanced Antibacterial Research Workflows

  2026-07-09

  Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, empowers researchers to dissect Gram-positive, Gram-negative, and intracellular infection models with exceptional precision. This article delivers practical protocols, troubleshooting guidance, and comparative insights for maximizing experimental reliability in respiratory, mycobacterial, and complex infection research.

• KN-62 Enables Precision CaMKII Inhibition in Cell Signaling

  2026-07-09

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, stands out as a highly selective CaMKII inhibitor for dissecting calcium-dependent signaling and metabolic regulation. This article details experimental workflows, troubleshooting strategies, and advanced applications that maximize the interpretive power of KN-62 in cell biology and metabolic research.

• Flubendazole in Autophagy Modulation: Protocols & Research I

  2026-07-08

  Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) is redefining autophagy modulation research with its robust DMSO solubility and high purity, enabling deeper mechanistic studies in cancer and fibrosis models. This guide offers practical workflows, troubleshooting insights, and a bridge to the latest findings on metabolic regulation in hepatic stellate cells.

• Aztreonam: Monocyclic β-Lactam Antibiotic Workflows & Insigh

  2026-07-08

  Aztreonam stands out as a synthetic monocyclic β-lactam antibiotic, uniquely targeting Gram-negative aerobic bacteria and enabling advanced experimental workflows in resistance and metabolic research. This article distills protocol enhancements, troubleshooting strategies, and translational advantages for researchers leveraging Aztreonam in multidrug resistance studies.

• Ferritin-Based Hybrid Vaccine Targets Influenza and SARS-CoV

  2026-07-07

  This study introduces a ferritin-based hybrid protein particle vaccine co-displaying the M2e antigen of influenza A and S-protein tandem epitopes from SARS-CoV-2. The approach leverages ferritin's self-assembly to enhance immunogenicity and provides a scalable, versatile platform for next-generation combination vaccines.

449 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page